Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer

ABSTRACT: RATIONALE: Octreotide may be effective in preventing diarrhea that is caused by treatment with irinotecan. PURPOSE: Randomized phase III trial to study the effectiveness of octreotide in preventing diarrhea in patients who are receiving irinotecan for metastatic colon cancer.

DISEASE(S): Diarrhea,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2005313 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR